Societal CDMO to Participate at 35th Annual Roth Conference

Rhea-AI Summary

Societal CDMO (NASDAQ: SCTL) announced its participation in the 35th Annual Roth Conference from March 12-14, 2023, at The Ritz Carlton, Laguna Niguel, California. The company focuses on contract development and manufacturing for small molecule therapeutics, offering solutions for complex formulation challenges. At the conference, management will engage in 1-on-1 meetings with potential partners. With facilities in Gainesville, Georgia, and San Diego, California, Societal CDMO provides comprehensive services, including regulatory support and clinical manufacturing, aimed at delivering high-quality pharmaceutical products.

SAN DIEGO and GAINESVILLE, Ga., March 03, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that the company will participate at the 35^th Annual Roth Conference.

Details of the company’s participation are as follows:

• 35^th Annual Roth Conference
  Details: Societal management will participate in 1-on-1 meetings
  Conference Dates: March 12-14, 2023
  Location: The Ritz Carlton, Laguna Niguel in Dana Point, California

About Societal CDMO
Societal CDMO (NASDAQ: SCTL) is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. With an expertise in solving complex manufacturing problems, Societal CDMO is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.

In addition to our experience in handling DEA controlled substances and developing and manufacturing modified-release dosage forms, Societal CDMO has the expertise to deliver on our clients’ pharmaceutical development and manufacturing projects, regardless of complexity level. We do all of this in our best-in-class facilities, which total 145,000 square feet, in Gainesville, Georgia and San Diego, California.

Societal CDMO: Bringing Science to Society. For more information about Societal CDMO’s customer solutions, visit societalcdmo.com.

FAQ

What is Societal CDMO's participation in the 35th Annual Roth Conference?

Societal CDMO will participate in 1-on-1 meetings at the conference held from March 12-14, 2023.

Where is the 35th Annual Roth Conference being held?

The conference will be held at The Ritz Carlton, Laguna Niguel in Dana Point, California.

What is the focus of Societal CDMO?

Societal CDMO specializes in contract development and manufacturing, primarily for small molecule therapeutics.

What services does Societal CDMO provide?

The company offers therapeutic development, regulatory support, clinical and commercial manufacturing, and packaging services.

What is the stock symbol for Societal CDMO?

The stock symbol for Societal CDMO is SCTL.